🏛️ Verified NIH Record • Updated 2026-02-13
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight (NCT06962280)
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Long-Term Safety of Tirzepatide Once Weekly Compared to Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Eli Lilly and Company
🩺 Plain-English Summary (8th-Grade Level)
The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 20 months.
Who can join: Review the eligibility criteria below.
Location: Kaiser Permanente Bonita Medical Offices — Bonita, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (79 Sites)
Showing the first 25 of 79 sites.
- Kaiser Permanente Bonita Medical Offices — Bonita, California
- AMCR Institute — Escondido, California
- Mary & Dick Allen Diabetes Center — Newport Beach, California
- University Clinical Investigators, Inc. — Tustin, California
- University of Colorado Anschutz Medical Campus — Aurora, Colorado
- Metabolic Research Institute, Inc. — West Palm Beach, Florida
- Iowa Diabetes and Endocrinology Research Center — West Des Moines, Iowa
- HealthPartners Institute dba International Diabetes Center — Minneapolis, Minnesota
- Clinical Research Professionals — Chesterfield, Missouri
- Clinvest Headlands Llc — Springfield, Missouri
- Las Vegas Endocrinology — Henderson, Nevada
- University of North Carolina Medical Center — Chapel Hill, North Carolina
- Velocity Clinical Research, Dallas — Dallas, Texas
- Juno Research — Houston, Texas
- Southern Endocrinology Associates — Mesquite, Texas
- Texas Diabetes & Endocrinology, P.A. — Round Rock, Texas
- San Antonio Clinical Trials — San Antonio, Texas
- Texas Valley Clinical Research — Weslaco, Texas
- Buenos Aires Macula S.A — Buenos Aires,
- Stat Research S.A. — Buenos Aires,
- Mautalen Salud e Investigación — Buenos Aires,
- Centro Diabetológico Dr. Waitman — Córdoba,
- CIPADI - Centro Integral de Prevencion y Atencion en Diabetes — Godoy Cruz,
- Centro de Investigaciones Clínicas Baigorria — Granadero Baigorria,
- Instituto Médico Catamarca IMEC — Rosario,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type 1 Diabetes
- A 12-week Pilot Nutrition Intervention for Children With New Diagnosis of Stage 3 Type 1 Diabetes (T1D) — Hershey, Pennsylvania
- Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families — Jacksonville, Florida
- Diabetes Inspired Culinary Education (DICE): Culinary Medicine Intervention for At-Risk Youth With Type 1 Diabetes — Cleveland, Ohio
- GO TEAM: Glucose Optimization Through Technology Assisted Management — Cleveland, Ohio
- REAL-Fam Feasibility Study for Youth Diabetes Management — Chapel Hill, North Carolina
- Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes — New York, New York
Explore by condition: All Type 1 Diabetes clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.